Barclays’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
494,415
-7,028
| -1% | -$19.2K | ﹤0.01% | 2468 |
|
|
2025
Q1 | $842K | Buy |
501,443
+182,960
| +57% | +$307K | ﹤0.01% | 2541 |
|
|
2024
Q4 | $519K | Sell |
318,483
-427
| -0.1% | -$696 | ﹤0.01% | 3028 |
|
|
2024
Q3 | $1.33M | Buy |
318,910
+178,179
| +127% | +$740K | ﹤0.01% | 2445 |
|
|
2024
Q2 | $769K | Buy |
140,731
+24,720
| +21% | +$135K | ﹤0.01% | 2266 |
|
|
2024
Q1 | $1.16M | Sell |
116,011
-234,603
| -67% | -$2.35M | ﹤0.01% | 2299 |
|
|
2023
Q4 | $1.43M | Buy |
350,614
+145,047
| +71% | +$592K | ﹤0.01% | 2374 |
|
|
2023
Q3 | $797K | Buy |
205,567
+6,096
| +3% | +$23.6K | ﹤0.01% | 2249 |
|
|
2023
Q2 | $1.19M | Sell |
199,471
-17,377
| -8% | -$104K | ﹤0.01% | 2045 |
|
|
2023
Q1 | $710K | Sell |
216,848
-86,262
| -28% | -$282K | ﹤0.01% | 2377 |
|
|
2022
Q4 | $1.2M | Buy |
303,110
+9,883
| +3% | +$39K | ﹤0.01% | 2002 |
|
|
2022
Q3 | $1.76M | Buy |
293,227
+264,030
| +904% | +$1.58M | ﹤0.01% | 1746 |
|
|
2022
Q2 | $188K | Sell |
29,197
-20,753
| -42% | -$134K | ﹤0.01% | 3166 |
|
|
2022
Q1 | $412K | Buy |
+49,950
| New | +$412K | ﹤0.01% | 2920 |
|